Grants>Heart

Summer 2013 - Mentored Clinical and Population Research Award

Application deadline: July 18, 2013

Award Activation Date:  Jan. 1, 2014

Applications must be received no later than 5:00 p.m. CDT on the deadline date.  The system will shut down at 5:00 p.m. CDT.  Early submission is encouraged.  Your institutional Grants Officer (GO) has the final responsibility of submitting your completed application to the American Heart Association.  It is important that you check with your GO for his/her internal deadline.

Objective

To encourage early career investigators who have appropriate and supportive mentoring relationships to engage in high quality introductory and pilot clinical studies that will guide future strategies for reducing cardiovascular disease and stroke while fostering new research in clinical and translational science, and encouraging community- and population-based activities.

This grant does not fund basic science or support senior researchers, but encourages mentoring of early career investigators.

Science Focus

Funding is available for research related to cardiovascular disease and stroke prevention or treatment, or to related clinical and public health problems, including multidisciplinary efforts.  Proposals are encouraged on provider behavior, patient behavior, behavioral outcomes, risk factor outcomes, disease outcomes, cost benefit analyses, efforts to evaluate outcomes of patient care delivery and patient/provider and/or system compliance and adherence to recommendations, as well as pilot clinical research studies that may provide preliminary data for larger-scale investigation. Studies using existing databases are also encouraged.  Ancillary studies or a clearly defined sub-study of an ongoing clinical research study are also encouraged. There must, however, be clear justification that the proposal is a sub-study and not a piece of an already funded project.

Target Audience

• Healthcare professional with a masters or post-baccalaureate doctoral degree, including M.P.H., R.N., Pharm.D., M.D., D.O. or Ph.D. 

• Interdisciplinary research teams are eligible.

Individuals are not eligible to be the principal investigator if they hold or have held:

• Certain NIH awards (such as RO1, R21, PO1)

• Certain AHA awards (BGIA, SDG, EIA, GIA); or

• An award equivalent to any of the above (an independent investigator award)

Citizenship

At the time of application, must have one of the following designations:

• U.S. citizen

• Permanent resident

• Pending permanent resident.  Applicant must have applied for permanent residency and have filed form I-485 with the U.S. Citizenship and Immigration Services and have received authorization to legally remain in the U.S. (having filed an Application for Employment form I-765)

• E-3 Visa - specialty occupation worker

• H1-B Visa - temporary worker in a specialty occupation

• F-1 - Student Visa - temporary worker in a specialty occupation

• J-1 Visa - exchange visitor

• O-1 Visa - temporary worker with extraordinary abilities in the sciences

• TN Visa - NAFTA Professional

• G-4 Visa - family member of employee of international organizations and NATO

Awardee must meet American Heart Association citizenship criteria throughout the duration of the award.

Applicants are not required to reside in the United States for any period before applying for American Heart Association funding.

Sponsor

All applicants must  identify a sponsor with an earned doctorate and a track record of high quality clinical investigation.

Annual Budget - National

Salary/Fringe:   Up to $35,000 per year for salary and fringe of the principal investigator, collaborating investigator(s), and other participants with faculty appointments, including an allowance of up to $5,000 for the sponsor.

Institution may supplement stipend.

Indirect:  10 percent ($7,000)

Project Support:  Project-related expenses, such as salaries of technical personnel, consultative services, supplies, equipment, computer/electronics, travel, volunteer subject costs, publication costs, within the following limits:

• Travel - $3,000 per year; international travel must have prior AHA approval.

• Computer purchase - National allows $5,000 for computer equipment/electronics. 

Maximum Annual Award Amount:  $77,000

Award Duration:  Two years

Total Award Amount:  $154,000

Children's Cardiomyopathy Foundation Research Grant Program

CCF's grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding by the National Institutes of Health and other major granting institutions.
Eligibility:

Principal investigator must hold an M.D., Ph.D. or equivalent degree and reside in the United States or Canada. The investigator must have a faculty appointment at an accredited U.S. or Canadian medical institution and have the ability to conduct independent research with publications in established peer-reviewed medical and scientific journals.
Funding:

Funding is available in the range of US$25,000 to US$50,000 for one year of total direct costs. Following the completion of the proposed study, a second year of funding may be requested by application. Upon receipt of a signed CCF letter of agreement and IRB or IACUC approval, CCF will disburse funds in installments during the grant period.
Application Process:

CCF requires a letter of intent in advance of the grant application. The 2013 deadline for Letters of Intent is Friday, June 14 by 5:00 p.m. Eastern Standard Time. Only investigators who have submitted a Letter of Intent and have been invited to submit a formal grant application will be considered for CCF funding.

The submission deadline for full grant applications is Friday, September 6, 2013 by 5:00 p.m. Eastern Standard Time with final award decisions to be made in January 2014.

Selection Process:

Grant award decisions are made through a careful and detailed peer-review selection process led by CCF's Medical Advisors and approved by CCF's Board of Directors. A study's scientific excellence and relevance to primary forms of pediatric cardiomyopathy is key to being selected for research funding. Details about the grant review process can be obtained by downloading CCF's Grant Requirements & Guidelines document.